N-苯乙基苯甲酰胺 | 3278-14-6

• 物质功能分类: 化学试剂 - 有机试剂 - 酰胺
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: N-苯乙基苯甲酰胺
• 中文别名: N-苯甲酰基-beta-苯乙胺；4-二氯甲基吡啶盐酸盐；N-苯乙基-苯甲酰胺
• 英文名称: N-phenethylbenzamide
• 英文别名: N-(2-phenylethyl)benzamide；riparin A；N-(2-phenethyl) benzamide；N-phenylethylbenzamide；N-(β-phenethyl)benzamide
• CAS: 3278-14-6
• 化学式: C₁₅H₁₅NO
• mdl: MFCD00441484
• 分子量: 225.29
• InChiKey: DAVRGGJTJDTVQT-UHFFFAOYSA-N

物化性质

• 熔点：
  117-118 °C
• 沸点：
  439.0±24.0 °C(Predicted)
• 密度：
  1.088±0.06 g/cm3(Predicted)
• 溶解度：
  溶于氘代氯仿

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  17
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.133
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2924299090
• 储存条件：
  2-8°C

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: N-Phenethyl-benzamide
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: N-Phenethyl-benzamide
CAS number: 3278-14-6

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C15H15NO
Molecular weight: 225.3

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

用途

N-（2-苯乙基）苯甲酰胺是一种苯胺类衍生物，主要用作化工医药中间体，在化工和医药合成过程中发挥重要作用。

制备方法

一种N-（2-苯乙基）苯甲酰胺的制备方法是将苯甲酰氯或苯甲酸、苯乙胺与碱金属氢氧化物及水混合后进行反应，最终得到所需的N-（2-苯乙基）苯甲酰胺。

反应信息

• 作为反应物：
  描述：

  N-苯乙基苯甲酰胺 在 五氯化磷 作用下， 生成 邻氯乙苯
  参考文献：
  名称：

  v. Braun, Chemische Berichte, 1911, vol. 44, p. 2872

  摘要：

  DOI：
• 作为产物：
  描述：

  2-(benzoylamino)-1-phenylethanol 在 钯 、 溶剂黄146 作用下， 生成 N-苯乙基苯甲酰胺
  参考文献：
  名称：

  Kindler; Hedemann; Schaerfe, Justus Liebigs Annalen der Chemie, 1948, vol. 560, p. 215,219

  摘要：

  DOI：
• 作为试剂：
  描述：

  2,2,6,6-四甲基哌啶氧化物 、 苯甲醛 在 叔丁基过氧化氢 、 N-苯乙基苯甲酰胺 、 copper(II) acetate monohydrate 作用下， 以40%的产率得到(2,2,6,6-四甲基哌啶-1-基)苯甲酸酯
  参考文献：
  名称：

  通过C–H键活化一键合成醛和胺的酰胺

  摘要：

  已经开发了由醛类与N-氯胺由醛类一锅法合成的酰胺，它是由胺原位制备的。脂族和芳族醛以及许多类型的单取代和二取代的胺都可耐受这种转化。这种交叉偶联反应看起来简单方便，具有广泛的底物范围，并使用廉价，丰富且易于获得的试剂。

  DOI：

  10.1021/ol302175v

文献信息

• 一种利用嘧啶类缩合剂点击构建酰胺键的方法及其在酰胺和多肽合成中的应用
  申请人：兰州大学

  公开号：CN112851536B

  公开（公告）日：2022-02-25

  本发明公开了一种利用嘧啶类缩合剂点击构建酰胺键的方法及其在酰胺和多肽合成中的应用。其中，酰胺键的构建方法为：在羧酸组分和胺组分中加入溶有有机碱的有机溶剂，搅拌反应后加入溶有嘧啶类缩合剂的有机溶剂，继续搅拌反应后浓缩、分离纯化，得到酰胺或多肽产物。本发明酰胺键构建方法缩合剂使用量少，且缩合剂本身安全无味易储存，具有很好的原子经济性。所述酰胺键构建反应时间仅需数秒至十分钟，极大地缩短了酰胺或多肽合成时间。另外，本发明酰胺键构建反应也可在有机相‑水相的双相体系，以及在有机相‑水相的双相体系和不添加碱的条件下也能快速发生，这为对碱敏感的生物体系中的酰胺键构建反应提供了一种温和可行的路径。
• Allenone-Mediated Racemization/Epimerization-Free Peptide Bond Formation and Its Application in Peptide Synthesis
  作者：Zhengning Wang、Xuewei Wang、Penghui Wang、Junfeng Zhao

  DOI：10.1021/jacs.1c04614

  日期：2021.7.14

  peptide synthesis (SPPS). The robustness of the allenone-mediated peptide bond formation was showcased incisively by the synthesis of carfilzomib, which involved a rare racemization-/epimerization-free N to C peptide elongation strategy. Furthermore, the successful synthesis of the model difficult peptide ACP (65–74) on a solid support suggested that this method was compatible with SPPS. This method combines

  Allenone 首次被鉴定为一种高效的肽偶联剂。肽键以α-羰基乙烯基酯为关键中间体形成，其形成和随后的氨解以无外消旋/差向异构化的方式自发进行。丙二烯酮偶联试剂不仅对简单酰胺和二肽的合成有效，而且还适用于肽片段缩合和固相肽合成 (SPPS)。卡非佐米的合成充分展示了丙二烯酮介导的肽键形成的稳健性，该合成涉及一种罕见的无消旋化/差向异构化的 N 到 C 肽延伸策略。此外，在固体支持物上成功合成模型困难肽 ACP (65-74) 表明该方法与 SPPS 兼容。该方法结合了传统活性酯和偶联剂的优点，同时克服了两种策略的缺点。因此，这种丙二烯酮介导的肽键形成策略代表了肽合成的颠覆性创新。
• A Versatile Cyclodehydration Reaction for the Synthesis of Isoquinoline and β-Carboline Derivatives
  作者：Mohammad Movassaghi、Matthew D. Hill

  DOI：10.1021/ol801264u

  日期：2008.8.21

  beta-carboline derivatives via mild electrophilic amide activation, with trifluoromethanesulfonic anhydride in the presence of 2-chloropyridine, is described. Low-temperature amide activation followed by cyclodehydration upon warming provides the desired products with short overall reaction times. The successful use of nonactivated and halogenated phenethylene derived amides, N-vinyl amides, and optically active

  描述了在 2-氯吡啶存在下使用三氟甲磺酸酐通过温和的亲电酰胺活化将各种酰胺直接转化为异喹啉和 β-咔啉衍生物。低温酰胺活化，然后在加热时环化脱水，提供具有较短总反应时间的所需产物。非活化和卤化苯乙撑衍生酰胺、N-乙烯基酰胺和光学活性底物的成功使用是值得注意的。
• Sulfated tungstate: a highly efficient catalyst for transamidation of carboxamides with amines
  作者：Sagar P. Pathare、Ashish Kumar H. Jain、Krishnacharya G. Akamanchi

  DOI：10.1039/c3ra00127j

  日期：——

  An environmentally benign protocol for the transamidation of carboxamides with amines using sulfated tungstate, as a heterogeneous catalyst, has been developed. The method has been successfully applied to the synthesis of a wide range of aromatic and aliphatic amides and phthalimides. Efficient transformation, mild reaction conditions, easy product isolation and the potential reusability of the catalyst

  已经开发出一种环境友好的方案，用于使用硫酸化钨酸盐作为非均相催化剂将羧酰胺与胺进行氨基转移。该方法已成功应用于多种芳族和脂族酰胺和邻苯二甲酰亚胺的合成。高效的转化，温和的反应条件，容易的产物分离和催化剂的潜在可重复使用性是吸引人的特征。
• [EN] PYRROLE COMPOUNDS FOR THE TREATMENT OF PROSTAGLANDIN MEDIATED DISEASES<br/>[FR] COMPOSES PYRROLIQUES DESTINES AU TRAITEMENT DE MALADIES INDUITES PAR PROSTAGLANDINE
  申请人：GLAXO GROUP LTD

  公开号：WO2003101959A1

  公开（公告）日：2003-12-11

  Compounds of formula (I) or a pharmaceutically acceptable derivative thereof: wherein A, R1, R2a, R2b, Rx, R8, and R9 are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine, in particular their use in the treatment of prostaglandin mediated diseases such as pain, inflammatory, immunological, bone, neurodegenerative or renal disorder.

  式(I)的化合物或其药学上可接受的衍生物：其中A、R1、R2a、R2b、Rx、R8和R9如规范中所定义，一种制备这种化合物的方法，包括这种化合物的药物组合物以及这种化合物在医学中的用途，特别是它们在治疗前列腺素介导的疾病，如疼痛、炎症、免疫、骨骼、神经退行性或肾脏疾病中的用途。